Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
Learn More
Selleck Chemical LLC Inbrx-105-A4023-1MG
Supplier: Selleck Chemical LLC A40231MG
Inbrx-105 is a recombinant humanized bispecific antibody targeting programmed death-ligand 1 (PD-L1) and 4-1BB with potential checkpoint inhibitory immunostimulating and antineoplastic activities By binding to 4-1BB on activated T lymphocytes and PD-L1 on tumor cells INBRX-105 enhances T-cell co-stimulation and inhibits PD-L1-mediated T-cell inhibition potentially leading to reduced tumor growth INBRX-105 exhibits antitumor efficacy and increased T-cell frequency in patients with solid tumors and in in-vivo MW 101 9 KD
Product Title
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.
Spot an opportunity for improvement?